Skip to main content
logo
Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
27.87
+0.27 (0.98%)
Feb 4, 2026, 3:15 PM EST - Market open

Enliven Therapeutics Employees

Enliven Therapeutics had 65 employees as of September 30, 2025. The number of employees increased by 8 or 14.04% compared to the same quarter last year.

Employees
65
Change
8
Growth
14.04%
Revenue / Employee
n/a
Profits / Employee
-$1,495,492
Market Cap
1.65B

Employees Chart

Employees History

DateEmployeesChange (1Y)Growth (1Y)
Sep 30, 202565814.04%
Jun 30, 2025631121.15%
Mar 31, 2025651530.00%
Dec 31, 2024621634.78%
Sep 30, 2024571329.55%
Jun 30, 2024521540.54%
Mar 31, 2024502172.41%
Dec 31, 2023461758.62%
Sep 30, 2023442083.33%
Jun 30, 2023371354.17%
Mar 31, 202329--
Sep 30, 202224--

Related Stocks

Company NameEmployees
Immunocore Holdings493
Agios Pharmaceuticals488
Celldex Therapeutics186
Monte Rosa Therapeutics147
Precigen143
RAPT Therapeutics60
Tyra Biosciences60
Oculis Holding AG49
Employee Rankings

ELVN News

More News